F, V., MC, F., S, S., C, P., A, G., A, A., . . . A, R. (2026). Outcomes of allogeneic hematopoietic stem cell transplantation in patients with blast phase myelofibrosis: Molecular signature and intensive chemotherapy matter. Clinical and experimental medicine. https://doi.org/10.1007/s10238-026-02191-7
Chicago Style (17th ed.) CitationF, Valsecchi, et al. "Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Blast Phase Myelofibrosis: Molecular Signature and Intensive Chemotherapy Matter." Clinical and Experimental Medicine 2026. https://doi.org/10.1007/s10238-026-02191-7.
MLA (9th ed.) CitationF, Valsecchi, et al. "Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Blast Phase Myelofibrosis: Molecular Signature and Intensive Chemotherapy Matter." Clinical and Experimental Medicine, 2026, https://doi.org/10.1007/s10238-026-02191-7.